Found: 3
Select item for more details and to access through your institution.
IKZF1<sup>plus</sup> is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1337954
- By:
- Publication type:
- Article
Epidemiology of childhood acute leukemias in marginalized populations of the central-south region of Mexico: results from a population-based registry.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1304263
- By:
- Publication type:
- Article
Subclassification of B-acute lymphoblastic leukemia according to age, immunophenotype and microenvironment, predicts MRD risk in Mexican children from vulnerable regions.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2023.1304662
- By:
- Publication type:
- Article